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ABSTRACT
Epithelial–mesenchymal transition (EMT) contributes to the progression of renal tubulointerstitial fibro-
sis. The N-methyl-D-aspartate receptor (NMDAR), which is present in proximal tubular epithelium, is a
glutamate receptor that acts as a calcium channel. Activation of NMDAR induces actin rearrangement in
cells of the central nervous system, but whether it helps maintain the epithelial phenotype of the
proximal tubule is unknown. Here, knockdown of NMDAR1 in a proximal tubule cell line (HK-2) induced
changes in cell morphology, reduced E-cadherin expression, and increased -SMA expression. Induction
of EMT with TGF-1 led to downregulation of both E-cadherin and membrane-associated -catenin,
reorganization of F-actin, expression of mesenchymal markers de novo, upregulation of Snail1, and
increased cell migration; co-treatment with NMDA attenuated all of these changes. Furthermore, NMDA
reduced TGF-1–induced phosphorylation of Erk1/2 and Akt and the activation of Ras, suggesting that
NMDA antagonizes TGF-1–induced EMT by inhibiting the Ras-MEK pathway. In the unilateral ureteral
obstruction model, treatment with NMDA blunted obstruction-induced upregulation of -SMA, FSP1,
and collagen I and downregulation of E-cadherin. Taken together, these results suggest that NMDAR
plays a critical role in preserving the normal epithelial phenotype and modulating tubular EMT.
J Am Soc Nephrol 22: 1099–1111, 2011. doi: 10.1681/ASN.2010070701
Epithelial–mesenchymal transition (EMT) represents
a dynamic course of events that characterizes physio-
logic developmental processes and pathologic condi-
tions such as fibrosis and carcinogenesis.1,2 Tubular
EMThasbeendescribedasoneof thekeymechanisms
in the pathogenesis of renal fibrosis,3 where fibroblast
activation represents an important pathway for pro-
gressionof chronic kidneydisease.4 In vivo and in vitro
studies indicate that the major percentage of fibro-
blasts in the damaged kidney could originate from the
tubular epithelium through the process of EMT.5,6 In
the unilateral ureteral obstruction (UUO) model of
kidney fibrosis, Iwano et al.5 showed that 36% of in-
terstitial fibroblastsoriginate fromEMTof tubular ep-
ithelial cells. Tubular EMT is characterized by the loss
of intercellular contacts causedby thedownregulation
of E-cadherin, relocation of -catenin from the cell
periphery into the nucleus, de novo expression of
-SMA and vimentin, actin cytoskeleton reorganiza-
tion, tubular basement membrane destruction, and
enhanced cell migration.2,7
The N-methyl-D-aspartate receptor (NMDAR)
is a member of a heterogeneous family of iono-
tropic glutamate receptors, with important roles
within the CNS.8 NMDAR is a heteromeric protein
composedof an essentialNR1 subunit combinedwith
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oneormoreNR2 subunits9 that forma chan-
nel highly permeable to Ca2. Activation of
NMDAR requires simultaneous binding of
glutamate and glycine, leading to the channel
opening and Ca2 influx. NMDA, a non-
metabolic agonist of NMDAR, mimics the
action of glutamate regulating only this re-
ceptor. In addition to NMDAR’s broad dis-
tribution in neurons, it has become evident
that functionalNMDAR is also expressed in a
variety of non-neuronal cells and tissues.10–16
Importance of NMDAR in the kidney and its
functional role has emerged as an interesting
research topic, although experimental data
are scarce. Results fromDeng et al.16 showed
the presence of NMDAR1 subunit in the ba-
solateral proximal tubules of the rat kidney and confirmed a role
for renal NMDAR in the regulation of renal vasodilatation. Re-
cently, this group showed that renal NMDARs independently
stimulate proximal tubular reabsorption and glomerular filtra-
tion.17 Furthermore, it has recently been reported thatNMDARis
present inpodocyteswhere glutamatergic signaling contributes to
the integrity of the glomerular filtration barrier.18 However, the
function of NMDAR in tubular cells is not yet fully understood.
Awide spectrumof cellular functions in avarietyof cell types is
being controlled by the activity of ion channels. Although the ac-
tivity of calcium channels is important in the regulation of cell
migration,19–22 calcium signaling is significant inmediating actin
rearrangement23,24 and organization of cadherins and catenins
into intercellular junctions.25 Indeed, NMDAR activation has
been shown to induce changes in actin organization in cerebellar
granule cells26 and retinal neurons27 and to inhibit cell migration
in neurons19 and keratinocytes.20 Taking into consideration
knowledge of multiple characteristics of NMDAR in a variety of
tissues, including renal itself, we sought to examine its role in the
maintenance of the epithelial phenotype of proximal tubular ep-
ithelial cells (PTECs) and in tubular EMT in vitro. Furthermore,
we examined the role of channel activation in tubulointerstitial
fibrosis induced by UUO inmice.
RESULTS
NMDAR Subunit mRNA Expression in Human PTECs
Figure 1 shows the relative expression of NMDAR subunits in
HK-2 cells (human renal proximal tubular epithelial cells immor-
talized by transduction with human papilloma virus 16 E6/E7
genes). The results show that bothNMDAR1andNMDAR2Bare
expressed in this cell line. Thus, a functional NMDAR is expected
to be present in HK-2.
NMDA Treatment Increases the Ca2 Influx into the
HK-2 Cell
To examine whether NMDAR activation in HK-2 led to an
influx of Ca2 through the channel, cells were loaded with
Fluo-4 and incubated with NMDA. The treatment induced
significant influx of Ca2 into the cell, seen as a time-depen-
dent elevation in fluorescence signal detected by the calcium-
sensitive fluorophore (Supplementary Video 1).
Knockdown of NMDAR1 Influences PTEC Phenotype
To assess the function of the channel in basal conditions, the
expression of the NMDAR1 subunit was disrupted by short
hairpin RNA (shRNA). Figure 2, A and B, shows an evident
decrease inNMDAR1 expression inHK-2 infected with FSVsi-
NMDAR1 (shNR1) compared with FSVsi (control). Stun-
ningly, downregulation ofNMDAR1 inHK-2 induced changes
in the epithelial phenotype, evident as a decrease of E-cadherin
(Figure 2, C and D) and an increase of alpha-smooth muscle
actin (-SMA) (Figure 2, E and F), with the changes in cell
morphology toward the loss of cobble-stoned shape and the
acquisition of spindle-like form of loosely interconnected cells
(Figure 2, G and H). These results point to a role of basal
activation ofNMDAR inmaintaining the epithelial phenotype.
NMDAR Activation Reduces TGF-1–Induced EMT
In Vitro
Once it was determined that basal NMDAR activation had a
role in preserving the epithelial phenotype, we sought to assess
whether activation of the channel could be a possible strategy
in decreasing the change of phenotype in TGF-1–induced
EMT. Compared with control, TGF-1–treated cells started to
lose epithelial E-cadherin and gained -SMA (Figure 3, A and
B), whereas co-treatment with NMDA restored expression of
these molecules to the control level (Figure 3, A and B). Co-
incubation with TGF-1 and Thapsigargin (TG) did not result
in restoration of E-cadherin and -SMA expression in HK-2
(Figure 4, A and B), suggesting a specific effect of Ca2 entry
through NMDAR. Treatment with TGF-1 caused upregula-
tion of Snail1 in HK-2 within 6 hours (Figure 3, C and D) and
phosphorylation of Smad2/3 and its translocation into the nu-
cleus within 120 minutes after stimulation (Figure 3, E and F),
which was blunted by co-treatment with NMDA. Co-incuba-
tion with an antagonist of NMDAR (MK-801) abolished the
inhibitory effect of NMDA on TGF-1–induced upregulation
Figure 1. HK-2 cells express both NR1 and N2B subunit of NMDAR. Total RNA was
submitted to RT with an oligo dT reverse primer followed by PCR with different set
of primers for NMDAR subunits and GAPDH as an internal control. Representative
image after agarose gel electrophoresis shows differential expression of investi-
gated receptor subunits (NMDA R1370 bp; R2A300 bp; R2B376 bp; R2C397
bp; R2D280 bp).
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of Snail1, showing that the effect of NMDA was achieved
through the activation of the channel (Figure 4G). To confirm
that the influx of Ca2 through the activated NMDAR is the
one responsible for the preservation of the epithelial pheno-
type, we performed experiments in Ca2-free medium. In the
absence of Ca2 in the medium, NMDAR activation failed
to ameliorate TGF-1–induced downregulation of E-cadherin
and upregulation of Snail1 in HK-2 (Figure 4, H and I), as well
as to preserve characteristic cobble-stoned morphology of tu-
bular cells (Figure 4L), pointing again to an increase in extra-
cellular Ca2 flux as the responsible for NMDA effect.
TGF-1 induced significant changes in F-actin organiza-
tion seen as a strong increase in Phalloidin fluorescence,
whereas co-treatment with NMDA in-
hibited these changes (Figure 5A).
NMDA alone for 24 hours induced a sig-
nificant decrease of cellular F-actin in
HK-2 (Figure 5A). To rule out the possi-
bility that changes in F-actin distribution
were caused by changes in cell volume,
cell size was measured. NMDA did not
induce changes in cell volume (Supple-
mentary Figure 1C).
TGF-1 induced a loss of cobble-stoned
morphology and acquisition of spindle-like
shape, whereas co-treatment with NMDA
restored the epithelial phenotype of HK-2
(Figure 5C). Immunofluorescence showed
strong upregulation of vimentin in TGF-
1–treated cells (72 hours; Figure 5B) and
translocation of -catenin into the nucleus
(24 hours; Figure 5D), whereas co-treat-
ment with NMDA decreased expression of
vimentin and restored-catenin to its orig-
inal localization (Figure 5, B andD, respec-
tively).
NMDAR Activation Alters Human
PTEC Migration In Vitro
Wound Healing and Transwell Migration
Assay.
The role of NMDAR in human PTEC mi-
gration was studied using two different
migration assays. In the wound migra-
tion assay, NMDA treatment reduced
basal (Figure 6, G, H, and J; 48 hours) and
TGF-1–stimulated cell migration (Fig-
ure 6, A–F, J; 48 hours) after 24 and 48
hours. The transwell migration assay fol-
lowed the same pattern. As shown in Fig-
ure 6, I and K, NMDA reduced basal and
TGF-1–stimulated cell migration after
24 hours. To ensure that the decrease in
migration was not caused by the reduced
cell viability, an MTT (3-[4,5-dimethyl-
thiazol-2-yl]-2,5-diphenyltetrazolium
bromide) assay was performed. NMDA did not modify cell
viability (Supplementary Figure 1A).
Time-Lapse Phase Contrast Microscopy.
During migration, cells use different migrational modes to
move with varying degrees of speed and directionality28;
therefore, we examined the effect of NMDA on cell velocity
and persistence using time-lapse phase contrast micros-
copy. After 24 hours, NMDA reduced basal level of cell per-
sistence on fibronectin, as well as TGF-1–induced increase
in cell persistence on both tested matrices (Supplementary
Figure 2A).
Figure 2. NMDAR1 gene knockdown originates loss of epithelial phenotype in PTECs.
Representative Western blot (A) and quantitative analysis (B) show a decrease in
NMDAR1 expression in HK-2 infected with FSVsi-NMDAR1 (shNR1) compared with
FSVsi (control); *P  0.05 versus control. Downregulation of NMDAR1 in HK-2 induced
changes in epithelial phenotype, evident as a decrease of E-cadherin (C and D) and an
increase of -SMA (E and F). *P  0.05 versus control. (G and H) Representative
photomicrographs show morphologic changes in the shNR1 group of cells (H) com-
pared with control (G). Magnification: 20.
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To get more insights into the nature of PTECmigration, we
analyzed cell velocity. NMDA caused statistically significant
reduction of basal and TGF-1–induced cell velocity on both
tested matrices (Supplementary Figure 2B).
NMDAR Activation Reduces Phosphorylation of Erk1/2 and
Akt and Blocks Activation of Ras Induced by TGF-1
Treatment of HK-2 with TGF-1 resulted in a rapid in-
crease in phosphorylation of Akt (Figure 7, A and B) and
Erk1/2 (Figure 7, C and D) within 60 and 30 minutes after
stimulation, respectively, which was reduced by co-treat-
ment with NMDA. As shown in Figure 7, E and F, TGF-1
caused rapid activation of Ras within 10 minutes after stim-
ulation, whereas co-treatment with NMDA managed to re-
duce Ras-GTP down to control levels. Co-incubation with
TGF-1 and TG did not have the same effect on activation
of Ras (Figure 4, E and F) and phosphorylation of Erk1/2
(Figure 4, C and D) as NMDA treatment, pointing to spe-
cific effects of Ca2 entry through NMDAR. Furthermore,
in the absence of Ca2 in the medium, NMDAR activation
failed to reduce phosphorylation of Erk1/2 and Akt (Figure
4, J and K), suggesting again that the effect of NMDA is
mediated through increasing Ca2 influx.
NMDA Preserves Epithelial
Phenotype and Attenuates Renal
Fibrosis In Vivo
To study whether the effects of NMDA in
vitro could have a role in an in vivomodel of
EMT, mice underwent UUO and were
treated with NMDA. UUO induced
marked upregulation of -SMA and type
1 collagen at 5 (Figure 8A) and 15 days
(Figure 8B) after surgery compared with
contralateral controls. Administration of
NMDA significantly decreased -SMA
mRNA expression in obstructed kidneys at
both time points (Figure 8, A and B).
NMDA treatment showed a tendency to re-
duce collagen I mRNA 5 days after UUO
(Figure 8A), whereas at day 15 after UUO,
NMDA managed to significantly diminish
expression of collagen I in obstructed kid-
neys (Figure 8B). Figure 8, D–F, shows a
significant increase of -SMA protein in
the obstructed kidneys at days 5 and 15 af-
ter UUO compared with contralateral con-
trols. In accordance with mRNA data,
NMDA treatment inhibited -SMA at the
protein level (Figure 8, D–F). Of interest,
IHC staining showed an evident decrease of
epithelial cell marker E-cadherin in atro-
phic tubules (Figure 9A) and an increase of
-SMA (Figure 9B) and FSP1 (Figure 9C)
in the obstructed kidneys at day 15 after
UUO. Administration of NMDA managed
to inhibit the reduction of E-cadherin and increase in -SMA
and FSP1, preserving the epithelial phenotype (Figure 9).
As measured by Sirius red staining, all kidneys at day 15
after UUO showed a significant increase in interstitial colla-
gen deposition compared with contralateral kidneys (Figure
8C), which was also evident after Masson-Trichrome staining
(Figure 9D). NMDA-treated mice showed a significant de-
crease in interstitial collagen fibers in obstructed kidneys, as
measured by Sirius red (Figure 8C) and confirmed byMasson-
Trichrome (Figure 9D).
DISCUSSION
In this study, we described a new role for NMDAR in preserv-
ing renal tubular epithelial structure. Structural integrity of the
renal epithelium is of vital importance in the maintenance of
normal kidney function, and it depends in a great deal on the
formation and preservation of intercellular contacts, where an
important role is attributed to intracellular calcium.29,30
NMDAR is a heteromeric complex composed of highly orches-
trated subunits, whose activation triggers a series of Ca2-me-
diated intracellular events.31 In our study, in vitro activation of
Figure 3. NMDAR activation restored expression of E-cadherin, -SMA, Snail1, and
pSmad2/3 altered by TGF-1. HK-2 cells were incubated in serum-free medium
(control), TGF-1, or TGF-1  NMDA for 72 hours (E-cadherin, -SMA), 6 hours
(Snail1), or 120 minutes (pSmad2/3). Whole cell lysates were immunoblotted with
antibodies against E-cadherin, -SMA, and Snail1. The same samples were reprobed
with tubulin to ensure equal loading. Representative Western blots and quantitative
analysis show a decrease in E-cadherin (A and B) and an increase in -SMA (A and B)
and Snail 1 (C and D) expression induced by TGF-1. Co-treatment with NMDA
restored expression of these molecules close to control levels. (E and F) NMDA
managed to reduce TGF-1–induced translocation of pSmad2/3 into the nucleus after
120 minutes (nuclear extracts). Histone 1 was used as a loading control for pSmad2/3
expression. (B, D, and F) *P  0.05 versus control; #P  0.05 versus TGF-1.
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NMDAR is followed by an increase of intracellular Ca2,
showing that NMDAR in HK-2 is fully functional and its acti-
vation induces a fast and transient increase in intracellular
Ca2. The basal activation of NMDAR in tubular cells is indis-
pensable in the maintenance of the normal tubular epithelial
phenotype.On the one hand, knockdownofNMDAR1 expres-
sion in HK-2 cells using shRNA induced changes in epithelial
phenotype, evident as a decrease of E-cadherin and increase of
-SMA, along with the changes in cell morphology toward
mesenchymal phenotype. On the other hand, activation of the
channel in normal cells led to a decrease in basal cell motility
and F-actin content, two key steps in EMT that are modulated
by Ca2 levels.21–23 Taken together, these results point to an
indispensable role of basalNMDARactivity in the preservation
of the epithelial phenotype of PTECs.
Tightness of adherens junctions, and thus stability of the
epithelial phenotype, relies on cadherin–catenin complexes
linked to the actin cytoskeleton. These complexes are dis-
rupted in EMT caused by TGF-1, a potent inducer of fibro-
sis.32,33 In our model, after addition of TGF-1, HK-2 started
disassociating from neighboring cells and acquired spindle-
shapedmorphology, accompanied by the reorganization of the
actin cytoskeleton and elevated cell migration. Furthermore,
cells lost epithelialmarker E-cadherin, showed translocation of
-catenin into the nucleus, and acquired myofibroblast mark-
ers such as -SMA and vimentin. Treatment with NMDA
blunted all changes induced by TGF-1, showing that the ac-
tivation of the channel was able to preserve the epithelial phe-
notype in cells undergoing EMT.
Acquisition of migratory phenotype and reorganization of
actin cytoskeleton are prerequisites for effective migration of
transformed cells through the basementmembrane toward the
interstitium. Being aware of the existence of biochemical and
functional interactions between NMDAR subunits and cyto-
skeletal proteins,34,35 we sought to examine the influence of
NMDAR activation on migration and F-actin distribution in
HK-2. We showed by two independent in vitro migration as-
says that the activation of NMDAR has an inhibitory effect on
cell migration. Cell velocity data support the wound and trans-
well migration results and confirm the role of NMDAR in the
regulation of human PTEC migration. In addition, activation
of NMDAR decreases basal actin polymerization state and
TGF-1–induced actin reorganization in HK-2. The effect of
NMDAR activation and Ca2 on cell migration19,20 and actin
organization26,27 has previously been reported in different cell
types. Nahm et al.20 showed that Ca2 entry through activated
NMDAR inhibited keratinocyte outgrowth andmigration. Ki-
hara et al.19 reported that stimulation of NMDAR inhibited
neuronal migration in embryonic rat cerebral cortex. Further-
more, Cristofanilli and Akopian27 showed that the NMDAR
activation and influx of Ca2 caused a reduction of F-actin in
retinal neurons of salamander, whereas NMDAR activation in
rat cerebellar granule cells rapidly shifted F/G-actin equilib-
rium in favor of depolymerization.26
The role of NMDAR in preservation of tubular epithelial
phenotype was further confirmed in in vivo studies, in amouse
model of tubulointerstitial fibrosis induced by UUO. Consis-
tent with the in vitro results, significant changes in cell pheno-
type were seen in renal tubules in the obstructed kidneys such
as downregulation of E-cadherin, increase in -SMA expres-
sion and FSP1 immunostaining, and interstitial collagen depo-
sition.We provide evidence that NMDA treatment may atten-
uate renal fibrosis induced byUUOby preserving the epithelial
phenotype, as shown by the inhibition of the decrease in E-
cadherin induced by UUO. Furthermore, in obstructed kid-
neys of NMDA-treated mice, markers of the mesenchymal
phenotype (FSP1 and -SMA) were reduced, together with
collagen deposition, pointing to NMDAR as a possible thera-
peutic target to slow down the progression of renal fibrosis.
The mechanism behind the effect of NMDA on tubular
EMT seems to be related to the regulation of the activation of
Ras pathway. Ras is one of themost common pathways leading
to the activation of Erk and Akt, which represent important
signaling events responsible for TGF-1–induced EMT in dif-
ferent epithelial cell types.36–38 A growing body of evidence
describes the role of TGF-1 in the activation of Ras path-
way.39–41 In our own hands, TGF-1 treatment induced rapid
activation of Ras in HK-2 cells, which was blunted by co-treat-
ment with NMDA. This effect of NMDA inhibiting the Ras
pathway has previously been reported. Chandler et al.42 de-
scribed that different levels of Ca2 influx through NMDAR
could activate opposing stimulatory and inhibitory pathways
that regulate Erk activation and suggested the presence of a
Ca2-activated inhibitory pathway that can attenuate Ras/Erk
signaling. Ivanov et al.43 and Sutton and Chandler44 showed
that NMDAR-dependent activating/inactivating pathways
are spatially separated in neurons and that extrasynaptic
NMDARs, containing NR2B subunit, mediate Erk inactiva-
tion. Finally, Kim et al.45 showed that NMDAR activation
could have differential effects on Ras/Erk pathway in neurons
depending of the receptor subunit composition, showing that the
NR2B subunit is coupled to the inhibition rather than the activa-
tion of the Ras/Erk pathway.45 Our results showed that, in HK-2,
the NR2B subunit was the main NR2 subunit expressed. Down-
regulation of the Ras pathway by NMDA supports the subunit-
regulatory hypothesis and suggests that Ca2 influx through
NR2B-NMDARinHK-2couldbe responsible for the inactivation
of Ras and subsequently Erk and Akt pathways.
It is well known that Snail1 acts as a key regulator of EMT by
suppressing E-cadherin transcription andmodulating tight junc-
tionprotein expression,46–48 and it is crucial in initiation andpro-
gression of EMT.46,49 Moreover, it has been shown that Smad3 is
necessary for TGF-1–induced Snail1 gene expression in a study
using Smad3-null mice.50 Our results showed upregulation of
Snail1 and translocation of pSmad2/3 into the nucleus after treat-
ment with TGF-1, which was blunted by co-treatment with
NMDA, providing more proof of the inhibitory effect of NMDA
on EMT of PTECs. Additionally, pharmacologic blockade using
an antagonist ofNMDAR(MK-801) in cells treatedwithTGF-1
and NMDA eliminated downregulation of Snail1 induced by
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NMDA, showing that the above described effects are NMDAR
specific. These results could also be explained by the inhibition of
Ras activationwithNMDA. It has been shown that the inhibition
of Erk phosphorylation decreases TGF-1–induced Smad phos-
phorylation.51,52 Furthermore, it has also been shown that Ras
activation is necessary to increase Snail expression induced by TGF-
1.53 Thus, a decrease in Ras activation could explain both the de-
crease in the activation of the Erk pathway and the Smadpathway.
To show that the described changes are the consequence
of Ca2 influx exclusively through NMDAR, we used TG,
which has been previously shown to raise intracellular Ca2
concentrations in proximal tubular cells in culture.54 Treat-
ment with TG did not lead to the recovery of E-cadherin and
-SMA expression modified by TGF-1. Additionally, si-
multaneous incubation of HK-2 with TGF-1 and TG did
not prevent the activation of Ras and induced strong phos-
Figure 4. Calcium influx through NMDAR is responsible for the attenuation of TGF-b1-induced tubular EMT. (A–F) Thapsigargin does
not have the same inhibitory effect as NMDA treatment on TGF-1–induced alterations in HK-2 cells. HK-2 cells were incubated in
serum-free media (control), TGF-1, or TGF-1 Thapsigargin for 72 hours (E-cadherin and -SMA), 30 minutes (pErk), and 10 minutes
(Ras-GTP). Representative Western blots (A, C, and E) and quantitative analysis (B, D, and F) show that the incubation of HK-2 with
TGF-1 and TG for indicated periods of time did not have the same effect as NMDA treatment on expression of E-cadherin and -SMA
(A and B) nor induced decreases in phosporylation of Erk (C and D). (E) Total cell extracts were prepared and incubated with GST-RBD
to measure the amount of Ras-GTP (top panel). Aliquots of total cell lysates (10 g) were run in parallel for detection of total Ras protein
(bottom panel). Co-incubation of TG and TGF-1 did not induce deactivation of Ras, pointing to a specific effect of Ca2 entry through
NMDAR. (B, D, and F) *P  0.05 versus control. (G) Co-incubation of cells with MK-801 abolished the inhibitory effect of NMDA on
TGF-1–induced overexpression of Snail1. HK-2 cells were incubated for 6 hours in serum-free medium (control), TGF-1, TGF-1 
NMDA, TGF-1  NMDA  MK-801, TGF-1  MK-801, and MK-801 alone. Whole cell lysates were immunoblotted with antibody
against Snail1. The samples were reprobed with antibody against tubulin to ensure equal loading. (H–L) NMDAR activation failed to
ameliorate TGF-1–induced alterations in HK-2 cells in the absence of Ca2 in the culture media. HK-2 cells were incubated in serum
free medium (control), TGF-1, or TGF-1 NMDA (in serum free EpiLife [Ca2-free] medium) for 72 hours (E-cadherin), 6 hours (Snail),
and 30 minutes (pErk, pAkt). Representative Western blots (H and J) and quantitative analysis (I and K) show decreases in E-cadherin,
increases in Snail 1 expression, and phosphorylation of Erk and Akt induced by TGF-1. Co-treatment with NMDA in Ca2-free medium
does not modify TGF-1 effects. (I and K) *P 0.05 versus control. (L) Light microscopy shows morphologic changes caused by TGF-1
and NMDA treatment in Ca2-free medium. Magnification: 20.
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phorylation of Erk1/2, showing that Ca2 derived from
other sources did not have the same effect on preservation
of epithelial phenotype as Ca2 influx through NMDAR.
Furthermore, in the absence of Ca2 in themedium, NMDA
treatment failed to ameliorate TGF-1–induced changes in
expression of E-cadherin and Snail, as well as in phosphor-
ylation of Erk1/2 and Akt. These results point to a specific
role of Ca2 entry through the activated NMDAR in main-
taining the epithelial phenotype of PTECs.
Ca2 entry via NMDAR activates type I NO synthase,
which subsequently leads to vasodilatation in brain.55 The
kidney also contains type INOsynthase andvasodilates as a result
of NMDAR activation.16 Thus, there is a possibility that NMDA
administration could ameliorate renal fibro-
sis in vivo by a combined effect of inhibition
of tubular EMT and vasodilatation. Further
studies in this direction are required to ex-
plore this possibility.
In conclusion, basal NMDAR activa-
tion is essential for the maintenance of
the epithelial phenotype of PTECs. Fur-
thermore, activation of tubular NMDAR
attenuates EMT by blunting the TGF-
1–induced activation of Ras and the fol-
lowing cascades. Although no therapies
aimed to increase NMDAR activation are
available clinically, results obtained in
this study identified a new therapeutic
target for the inhibition of EMT and
treatment of related diseases.
CONCISE METHODS
In Vitro Study
Cell Culture and Treatments.
HK-2 cells56 obtained from ATCC were main-
tained in DMEM/F12 media (Life Technolo-
gies) supplemented with 2% FBS, Hepes buf-
fer, insulin, transferrin, sodium selenite,
glucose, dexamethasone, EGF, penicillin, and
streptomycin (Sigma Aldrich). Fresh growth
medium was changed every 2 to 3 days. Before
treatments, cells were growth arrested in se-
rum-free medium and incubated separately
with serum-free medium (control), TGF-1
(1.3 ng/ml; R&D Systems, Minneapolis, MN),
TGF-1  NMDA (0.5 mM; Sigma Aldrich),
TGF-1  TG (2 M), TGF-1  MK-801
(NMDAR antagonist; 0.1 mM), MK-801, or
NMDA alone for indicated periods of time.
Cells were maintained according to the de-
scribed protocol, unless otherwise indicated.
For the experiments in Ca2-free conditions,
EpiLife (calcium free) medium was purchased
from Life Technologies.
Digital Video Imaging of Ca2 Influx.
Cells were grown on glass coverslips in 2% FBS/DMEM/F12. After
reaching an adequate confluence, cells were washed with KREBS
solution (145 mMNaCl, 5 mMKCl, 2 mMCaCl2, 1 mMMgCl2, 10
mM Hepes buffer, and 11 mM glucose at pH 7.5) and incubated
with 5 M of Fluo-4AM (Molecular Probes) for 30 minutes at
37°C. Coverslips were assembled in a specific adaptor for the con-
focal microscope (Nikon TE-200), and digital video imaging of Ca2
influx was done over a 20-minute interval after treatment with NMDA
(0.5 mM). Images were taken every minute using100 objective at 485
nm of excitation and 528 nm of emission. For the control of the maxi-
Figure 5. NMDAR activation modulates important key steps in tubular EMT in vitro. (A)
Activation of NMDAR decreases basal actin polymerization state and TGF-1–induced
actin reorganization in HK-2 cells. Cells were grown in control conditions, TGF-1,
TGF-1  NMDA, and NMDA for 24 hours and examined by flow cytometry using
Phalloidin fluorescence detected on FL1 (as described in Concise Methods). Values are
given as percentage of the control (means  SEM) of three independent experiments
assayed in triplicate for every condition. *P  0.05 versus control; #P  0.05 versus
TGF-1. Immunofluorescence staining for the distribution of vimentin (B) and -catenin
(D) in HK-2 cells after incubation with TGF-1 or TGF-1 NMDA. TGF-1 induced de
novo expression of vimentin (72 hours) and translocation of -catenin (24 hours) into
the nucleus. Co-treatment with NMDA reduced vimentin expression and restored
-catenin to the cell periphery. (C) Light microscopy shows morphologic changes
caused by TGF-1 and NMDA treatment. Scale bar (B) 10 m; (C) 20 m. (D) Original
magnification: 40.
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mum level of fluorescence we used 10 M ionomycin (a calcium iono-
phore), and for the control of theminimum level of fluorescence, 5mM
EGTAwas used.
Flow Cytometry Analysis of Filamentous
Actin (F-Actin).
To investigate the possible effect of TGF-1 and NMDA on filamen-
tous actin in HK-2 cells, flow cytometry analysis was used. After 24
hours of incubation in described treatments,
cells were washed in PBS and briefly exposed to
Trypsin-EDTA (0.05%). Trypsinization was
stopped by dilution with 2% FBS/DMEM/F12,
and suspended cells were centrifuged at 2000
rpm for 5 minutes. Cell pellets were washed in
PBS and centrifuged at 2000 rpm for 5 min-
utes. HK-2 were fixed in 4% paraformalde-
hyde/PBS for 10 minutes, washed in PBS, and
incubated with 0.1% Triton X-100/PBS for 5
minutes. After centrifugation at 2000 rpm for
5 minutes, cells were incubated with 1% BSA/
PBS for 30 minutes. Cells were stained with Alexa
Fluor 488 phalloidin (Molecular Probes; dilu-
tion 1/150 in 1% BSA/PBS) for 1 hour in the
dark. Ten thousand HK-2 cells were aspirated
into a flow cytometer (Epics XL flow cytome-
ter). The resulting histogram is a measure of
phalloidin staining per cell, which is indica-
tive of the amount of F-actin structure to
which the fluorescence phallotoxin is bound.
In VitroWound Migration Assay.
HK-2 cells were grownuntil 100%of confluence
and were growth-arrested in serum-free me-
dium for 24 hours. Cell monolayer was injured
in a linear fashion with a sterile 200-l pipette
tip and gently washed with PBS. Treatments
were added, and the closure of the denuded area
was monitored using a LEICA Microsystems
DFC480 inverted microscope. Digital images
were obtained at 0, 24, and 48 hours (four im-
ages per treatment). The width of the wounds
was measured using LEICA Quantity Software
IM50 Image Manager V.4.0, and the progres-
sion ofmigrationwas computed by substracting
the width of the wound at 24 or 48 hours from
the initial width of the wound (at 0 hours). The
experiments were repeated three times, and ev-
ery treatment group was done in triplicate.
Transwell Migration Assay.
Transwell inserts (8-m porosity; Falcon, BD
Labware) were coated with 20 l of growth fac-
tor–free Matrigel (BD Bioscience) and incu-
bated at 37°C for 30minutes. After serumdepri-
vation, HK-2 cells were seeded (5 104) in the top well chambers in
200 l of DMEM/F12 with 0% FBS. The bottom compartments of
transwell chambers were filled with 500 l of DMEM/F12 with
10% FBS. Media in the top and bottom chambers were supple-
mented with the same concentrations of corresponding treat-
ments. After 24 hours, media were removed; cells were washed
with PBS and fixed with 4% paraformaldehyde for 10 minutes and
0.1% Triton X-100 for 5 minutes. Cells that remained on the upper
Figure 6. NMDAR activation inhibits basal and TGF-b1-stimulated PTEC migration in
vitro. (A–H) Wound healing assay. Contrast phase micrographs of HK-2 cells migrating
into the denuded area of the scratch wound at various times after monolayer wound-
ing. One representative experiment is shown to illustrate the wound closure after 48
hours in control conditions (B), TGF-1 (D), TGF-1  NMDA (F), and NMDA (H)
compared with the corresponding wounds at the point 0 hours for the control (A),
TGF-1 (C), TGF-1NMDA (E), and NMDA (G). (A–H) Magnification:4. (I) Transwell
migration assay. Representative photos show parts of transwell inserts for control,
TGF-1, TGF-1  NMDA, and NMDA treated group of cells after 24 hours of
incubation. Nuclei were stained with Hoechst. Magnification: 20. Quantification of
cell migration in wound healing assay after 24 and 48 hours (J) and transwell migration
assay after 24 hours (K). Data are presented as means  SEM (wound-healing assay) or
percentage of control (means values  SEM; transwell migration assay) of three
independent experiments assayed in triplicate for each time point and condition. (J)
*P 0.05 versus control at both time points and #P 0.05 versus TGF-1 at both time
points. (K) *P  0.05 versus control; #P  0.05 versus TGF-1.
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side of the filter membranes were gently removed with a cotton
swab. Membranes were cut out from the inserts with a scalpel
blade, and the cells from the bottom side of the membrane were
stained with 1% Hoechst (Sigma) (cell nuclei) for 10 minutes at
room temperature. Membranes were mounted on microscope
slides using ProLong antifade reagent (Molecular Probes), with the
lower surface facing up. Cells/nuclei were counted and analyzed
using a LEICA Microsystems DFC480 fluorescence microscope.
Fifty random fields were examined, and the results were plotted as
the percentage of control. The experiments
were repeated three times, and every treat-
ment group was performed in triplicate.
Live Cell Microscopy.
See Supplementary Material.
Analysis of Cell Migration in Time-Lapse
Movies.
See Supplementary Material.
Protein Nuclear Extraction.
HK-2 cells were serum deprived for 24 hours
and subsequently incubated in serum-free me-
dium (control), TGF-1, and TGF-1 
NMDA for 120 minutes. After incubation, cells
were washed with cold PBS. Nuclear protein
fraction was extracted using the NE-PER Nu-
clear and Cytoplasmic Extraction KIT (Pierce).
Expression of Fusion Protein GST-RBDRaf1
in Escherichia coli.
See Supplementary Material.
Determination of Ras Activation.
Ras activation was assessed by specific binding
of Ras-GTP (activated form) to the Ras binding
domain of Raf-1. For determination of Ras-
GTP, HK-2 cells were treated separately with se-
rum-free medium (control), TGF-1, TGF-1
NMDA, andTGF-1TG.After treatments,
cells were incubated with magnesium contain-
ing lysis buffer (25 mM HEPES [pH 7.5], 150
mMNaCl, 1% NP-40, 0.25% Na-deoxycholate,
10%glycerol, 25mMNaF, 10mMMgCl2, 1mM
EDTA, 1 mM Na3VO4, 2 mM PMSF, and pro-
tease inhibitor cocktail) for 10 minutes at 4°C.
Cells were cold centrifuged for 10 minutes at
10.000 rpm, and supernatant was collected.
After measurement of protein concentra-
tions, 10 g of lysate proteins was used in the
detection of total Ras after mixing with Laem-
mli sample buffer and boiling for 5 minutes.
Seventy micrograms of lysate proteins was in-
cubated with 2 g of GST-RBD precoupled
with glutathione-Sepharose at 4°C for 2
hours. The sepharose conjugates were recov-
ered by short centrifugation, washed two times with magnesium
containing lysis buffer, resuspended in Laemmli sample buffer,
and boiled for 5 minutes. Sample supernatants were subjected to
15% SDS-PAGE and used in Western blot detection of Ras-GTP.
Lentiviral Production and Infection of HK-2.
The shRNA vector was constructed by annealing complementary
60-mer oligonucleotides containing the 21-nucleotide target se-
Figure 7. NMDAR activation reduced phosphorylation of Erk and Akt and activation of
Ras induced by TGF-1 treatment. HK-2 cells were incubated in serum-free medium
(control), TGF-1, or TGF-1  NMDA for 30 and 60 (pErk, pAkt) and 10 minutes
(Ras-GTP). Representative Western blots (A, C, and E) and quantitative analysis (B, D,
and F) show alterations in protein expression induced by TGF-1 in HK-2 cells. NMDA
treatment reduced phosphorylation of Akt (A and B) and Erk (C and D) induced by
TGF-1 in HK-2 cells. After incubation with different treatments, whole cell lysates were
immunoblotted with either phospho-Akt or total-Akt and phospho-Erk or total-Erk. (E
and F) NMDA reduced TGF-1–induced activation of Ras. Total cell extracts were pre-
pared and incubated with GST-RBD to measure the amount of Ras-GTP (top panel).
Aliquots of total cell lysates (10 g) were run in parallel for detection of total Ras protein
(bottom panel). (B, D, and F) *P  0.05 versus control, #P  0.05 versus TGF-1.
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quence in both the sense and antisense orientation separated by a
9-nt spacer. The 21-mer sequence to NMDAR1 was CGCCAAC-
TACAGCATCATGAA and is predicted to be specific only for
NMDAR1 as determined by BLAST database searches. Oligonucle-
otides to produce shRNA were annealed in buffer (150 mM NaCl;
50 mM Tris, pH 7.6) and cloned into the AgeI-BamHI site of
Figure 8. NMDA treatment reduced -SMA and collagen I expression in the obstructed mouse kidney. (A and B) Real-time PCR analysis
shows downregulation of -SMA and collagen I mRNA expression in obstructed mouse kidney after NMDA treatment in different time
points (5 and 15 days). Relative mRNA levels were calculated and expressed as fold induction over contralateral controls (value  1.0)
after normalizing with GAPDH. *P  0.05 versus control; #P  0.05 versus UUO. (C) Quantification of collagen content after Sirius red
staining. Data are means  SEM of seven animals per group (n  7) *P  0.05 versus control; #P  0.05 versus UUO. (D and E) Western
blot shows increased expression of -SMA in the obstructed kidneys at 5 and 15 days after UUO and inhibition of -SMA in the UUONMDA
group of mice. Whole kidney lysates were processed for protein analysis at days 5 (D and F) and 15 (E and F) after UUO and were
immunoblotted with antibodies against -SMA and tubulin, respectively. (F) *P  0.05 versus control; #P  0.05 versus UUO.
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lentiviral vector for RNA interference-mediated gene silencing un-
der the control of U6 promoter for expression of short hairpin
shRNAs and the Venus variant of GFP under the control of SV40
promoter for monitoring transduction efficiency. To produce in-
fective lentiviral particles, 293T cells were co-transfected by the
polyethylenimine method with the virion packaging elements
(VSV-G and 8.9) and the shRNA-producing vector (FSVsi-
NMDAR1 or FSVsi as a control). 293T cells were allowed to pro-
duce lentiviral particles for 3 days in DMEM (Life Technologies)
supplemented with 10% FBS, sodium pyruvate, nonessential
amino acid, penicillin, and streptomycin. Culture medium was
collected and centrifuged at 3000 rpm for 10 minutes; supernatant
was collected and filtered using Sartorius filters at 4000 rpm for 30
minutes. Filtered supernatant was added to the growing culture of
HK-2 cells and incubated overnight. Next day, fresh medium was
replaced, and the cells were grown for an additional 3 to 4 days to
allow endogenous gene knockdown. Western blot and real-time
PCR were performed to check for gene knockdown.
In Vivo Study
This study was performed on female mice
(B6CBJ) weighing 18 to 22 g, obtained from
Charles River (Barcelona, Spain). Mice were
housed and maintained in a barrier facility, and
pathogen-free procedures were used in all
mouse rooms. Animals were kept in a 12-hour
light/dark cycle at 22°Cwith ad libitum access to
food andwater.Micewere randomly assigned to
two groups with seven mice each. Under gen-
eral anesthesia, mice were subjected to UUO
by double-ligating the left ureter using 2-0 silk
after a lateral abdominal incision. The UUO
 NMDA mice received NMDA treatment 3
days before and every day after the surgery (20
mg/kg body weight, intraperitoneally). UUO
mice received injections of the same volume
of the vehicle (0.9% saline solution). Five and
15 days after the surgery, animals from each
group were killed under general anesthesia.
One part of the obstructed kidney was fixed in
4% paraformaldehyde/PBS for histologic exami-
nations after embedding in paraffin. Another part
was frozen and kept at 80°C for protein and
mRNA extractions. All procedures performed in
this study followed the National Institute of
Health Guide for the Care and Use of Laboratory
Animals.
Semiquantitative PCR and Real-Time PCR.
See Supplementary Material.
Western Blot Analysis.
See Supplementary Material.
Immunofluorescence Microscopy.
See Supplementary Material.
Morphometric Analysis of Interstitial Fibrosis and IHC.
See Supplementary Material.
Statistical Analysis
Statistical significance was evaluated by t test or by one-way ANOVA
followed by a Tukey post hoc test (SPSS, Chicago, IL), as appropriate.
Values of P  0.05 were considered statistically significant. All data
examined are expressed as mean SEM.
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Figure 9. Activation of NMDAR in the mouse kidney attenuates renal fibrosis induced
by UUO; immunohistochemical staining for E-cadherin, -SMA, FSP1, and collagen I.
Administration of NMDA reduced the loss of E-cadherin (A) and decreased -SMA (B),
FSP1 (C), and collagen I (D) expression in the obstructed mouse kidney 15 days after
UUO. Kidney sections were stained with antibodies against E-cadherin (A), -SMA (B),
FSP1 (C), and with Masson-Trichrome staining (D). Representative photomicrographs
of kidney sections from three investigated groups of mice are presented. (A–C)
Original magnification: 20. (D) Scale bar, 20 m.
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